What Are the Results of the REVIVE-2 Trial?

Conference|ID Week

David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.

David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.

Related Videos
Related Content

World Tuberculosis Day: Easing the Continuum of Care Burden

March 24th 2023

Vaccine Race: Mei Mei Hu on Developing, Researching a COVID-19 Vaccine

October 21st 2020

Patient Perspective: Dealing With Recurrent C diff

March 6th 2023

Contagion® Connect Episode 4: Timothy Ray Brown's Advocacy for HIV Cure Research

November 19th 2019

Studying Islatravir/Doravirine for HIV Treatment-Naïve and Experienced Patients

February 27th 2023

Cryptococcal Meningitis: How Healthcare Access Can Make the Difference

February 26th 2023

World Tuberculosis Day: Easing the Continuum of Care Burden

March 24th 2023

Vaccine Race: Mei Mei Hu on Developing, Researching a COVID-19 Vaccine

October 21st 2020

Patient Perspective: Dealing With Recurrent C diff

March 6th 2023

Contagion® Connect Episode 4: Timothy Ray Brown's Advocacy for HIV Cure Research

November 19th 2019

Studying Islatravir/Doravirine for HIV Treatment-Naïve and Experienced Patients

February 27th 2023

Cryptococcal Meningitis: How Healthcare Access Can Make the Difference

February 26th 2023

World Tuberculosis Day: Easing the Continuum of Care Burden

March 24th 2023

Vaccine Race: Mei Mei Hu on Developing, Researching a COVID-19 Vaccine

October 21st 2020

Patient Perspective: Dealing With Recurrent C diff

March 6th 2023

Contagion® Connect Episode 4: Timothy Ray Brown's Advocacy for HIV Cure Research

November 19th 2019

Studying Islatravir/Doravirine for HIV Treatment-Naïve and Experienced Patients

February 27th 2023

Cryptococcal Meningitis: How Healthcare Access Can Make the Difference

February 26th 2023
© 2023 MJH Life Sciences

All rights reserved.